BlueFuse software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. It offers a clear, intuitive user interface; a common workflow; and scales for the needs of your lab. This widely implemented software is used in over 150 clinical research laboratories globally and for more than 80 percent of the PGS cycles currently being screened.
BlueFuse helps labs efficiently and confidently:
Screening embryos for aneuploidy prior to transfer has been shown to deliver significant improvements in IVF success (PGS)1. Preimplantation genetic diagnosis (PGD) enables screening of embryos for specific genetic conditions before transfer in an IVF procedure. BlueFuse Multi Software supplies laboratories with a single software solution for PGS and PGD.
Recent advances in microarray screening technologies have enabled identification of chromosomal microdeletions and microduplications (copy number variation). BlueFuse Multi software is sophisticated multi-user software for analyzing, visualizing, and interpreting results from molecular cytogenetics studies. With a clear, intuitive user interface, BlueFuse Multi generates accurate, user-independent results, quickly and efficiently.
BlueFuse is available to all users of Illumina cytogenetic and PGS/PGD products with unlimited licenses per site. It is not available as an open platform to other vendors of cytogenetics or PGS/PGD products.